Form 8-K - Current report:
SEC Accession No. 0000885590-23-000016
Filing Date
2023-05-04
Accepted
2023-05-04 07:08:46
Documents
14
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20230504.htm   iXBRL 8-K 38755
2 EX-99.1 ex991-q1x2023.htm EX-99.1 468782
6 image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-23-000016.txt   694960

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20230504.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20230504_lab.xml EX-101.LAB 25096
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20230504_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20230504_htm.xml XML 11484
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 23886419
SIC: 2834 Pharmaceutical Preparations